Previous experimental evidence based on middle cerebral artery occlusion mice indicated that TREM2 has crucial effects on stroke immune response, suggesting TREM2 could be a promising immunomodulation target in ischemic stroke [4, 13–16]. Here, TREM2 is linked to ischemic stroke.